NEA Management Company, LLC

CIK 0001512848 · TIMONIUM, MD · Quarter end: 2026-06-30 · Filed on: 2026-08-14 · Open the SEC source

NEA Management Company, LLC reported 26 positions worth $1.59B as of June 30, 2026 (13F filed August 14, 2026). Largest holding: TRVI (15.5%).

Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$1.59B
2026 Q2
Positions
26
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
89.8%
Est. Net Flow (Q)
2026 Q2
10 / 26 positions shown
#SymbolCompanyTypeValue% Port.Shares1YYTD
1TRVITrevi Therapeutics, Inc.SH$246.6M15.53%13,222,228
2MBXMBX Biosciences, Inc.SH$199.5M12.56%3,614,486
3GLUEMonte Rosa Therapeutics, Inc.SH$186.2M11.72%7,692,298
4CELCCelcuity Inc.SH$179.0M11.27%1,710,561
5SGPSpyglass Pharma, Inc.SH$164.6M10.36%7,392,301
6SVRASavara, Inc.SH$150.7M9.49%24,471,264
7ZBIOZenas BioPharma, Inc.SH$102.1M6.43%4,023,219
8COURCoursera, Inc.SH$72.6M4.57%12,867,769
9AUPHAurinia Pharmaceuticals, Inc.SH$67.4M4.24%3,969,834
10CRSPCRISPR Therapeutics AGSH$57.7M3.64%1,058,570

The free plan shows the top 10 positions. The remaining 16 positions, the full portfolio and quarter changes unlock with Pro.

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

Frequently Asked Questions

What stocks does NEA Management Company, LLC hold as of Q2 2026?

NEA Management Company, LLC reported 26 positions worth $1.59B in its Q2 2026 13F filing. Largest positions: TRVI (15.5%), MBX (12.6%), GLUE (11.7%), CELC (11.3%) and SGP (10.4%).

What did NEA Management Company, LLC buy in Q2 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did NEA Management Company, LLC sell in Q2 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.